Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction

Per Antonson1, Gertrud U Schuster, Ling Wang

  • 1Department of Biosciences at Novum, Karolinska Institutet, Novum, S-14157 Huddinge, Sweden. per.antonson@cbt.si.se

Insights

Genetic disruption of the nuclear receptor coactivator RAP250 causes embryonic lethality due to placental defects. This highlights RAP250

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • Nuclear receptors require coactivators for transcriptional activity.
  • RAP250 (also known as ASC-2/PRIP/TRBP/NRC) is an identified coactivator containing an LXXLL motif.
  • The precise biological functions and necessity of RAP250 remain to be fully elucidated.

Purpose of the Study:

  • To investigate the biological role of RAP250 by generating and analyzing Rap250 null mice.
  • To determine the impact of RAP250 deficiency on embryonic and placental development.
  • To assess the role of RAP250 in the transcriptional activity of nuclear receptors, specifically PPAR gamma.

Main Methods:

  • Gene targeting was employed to create Rap250 null mice.
  • Embryonic lethality was assessed at embryonic day 13.5.
  • Histological examination of placentas was performed to identify developmental abnormalities.
  • Transcriptional activity of PPAR gamma was measured in fibroblasts derived from Rap250(-/-) embryos.

Main Results:

  • Rap250 null mice exhibited embryonic lethality at embryonic day 13.5.
  • Placentas from Rap250(-/-) embryos showed a reduced spongiotrophoblast layer and collapsed blood vessels.
  • Transcriptional activity of PPAR gamma was diminished in Rap250(-/-) fibroblasts.
  • These placental defects suggest obstructed blood circulation as the cause of embryonic lethality.

Conclusions:

  • RAP250 is essential for normal placental development.
  • The absence of RAP250 leads to embryonic lethality, likely due to placental vascular complications.
  • RAP250 plays a crucial role as a coactivator for nuclear receptors like PPAR gamma in placental function.
  • RAP250 is indispensable for both placental and overall embryonic development.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...